We’re pouring billions into epigenetic reprogramming and AAV gene therapies on the flawed assumption that fixing the nucleus fixes the organism. It won't. This approach ignores the mechanical foreclosure of the extracellular matrix (ECM).

Human lung and skin collagen have half-lives measured in decades, not days. By seventy, your cells aren’t just "old"—they’re physically imprisoned in a bio-mechanical cage of non-enzymatic glycation cross-links and calcified elastic fibers. You can reset a fibroblast to a pluripotent state, but if you drop it back into a stiff, pro-inflammatory matrix, integrin-mediated mechanotransduction will force it back into a senescent phenotype within 72 hours. The physics of the environment serves as the primary instruction for the biology of the cell.

We need a moonshot for the Extracellular Chaperome.

I’m calling for a multi-disciplinary team to design a targeted "Matrix Refurbishment" protocol. We have to move beyond blunt protease delivery toward AAV-delivered, synthetic "molecular scissors"—enzymes engineered to selectively prune glucosepane cross-links and AGEs without wrecking the basement membrane’s structural integrity.

We’ve spent too long obsessed with the narrator (the genome) while ignoring the stage (the ECM). I want to fund a head-to-head experiment in aged murine models: OSKM reprogramming versus interstitial matrix de-stiffening. I suspect the matrix group will show far better functional longevity in high-stiffness tissues like the heart and vasculature.

We need protein chemists who understand non-canonical amino acid cross-linking and bioengineers who can model interstitial fluid dynamics. If we don't fix the scaffold, we’re just painting the walls of a collapsing house. It's time to stop funding the software and start funding the infrastructure.